Alerts will be sent to your verified email
Verify Email
NIDAN
|
Nidan Labs. & Health
|
Vimta Labs
|
Krsnaa Diagnostics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.89 % | 12.51 % | 8.55 % |
|
5yr average Equity Multiplier
|
1.8 | 1.33 | 1.35 |
|
5yr Average Asset Turnover Ratio
|
0.32 | 0.82 | 0.54 |
|
5yr Avg Net Profit Margin
|
5.91 % | 11.37 % | 11.94 % |
|
Price to Book
|
0.34 | 5.12 | 2.45 |
|
P/E
|
11.57 | 25.96 | 26.77 |
|
5yr Avg Cash Conversion Cycle
|
-378.19 Days | 122.88 Days | -61.33 Days |
|
Inventory Days
|
3.89 Days | 26.64 Days | 13.68 Days |
|
Days Receivable
|
13.34 Days | 95.75 Days | 115.54 Days |
|
Days Payable
|
205.76 Days | 309.83 Days | 297.83 Days |
|
5yr Average Interest Coverage Ratio
|
2.0 | 21.55 | 6.88 |
|
5yr Avg ROCE
|
11.91 % | 16.46 % | 11.9 % |
|
5yr Avg Operating Profit Margin
|
30.14 % | 25.53 % | 25.94 % |
|
5 yr average Debt to Equity
|
0.73 | 0.11 | 0.13 |
|
5yr CAGR Net Profit
|
-2.95 % | 43.08 % | 2.56 % |
|
5yr Average Return on Assets
|
2.0 % | 9.62 % | 6.39 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.04 % | 35.9 % | 27.11 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.18 % | -1.35 % | -0.69 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -1.48 % | -1.43 % |
|
Nidan Labs. & Health
|
Vimta Labs
|
Krsnaa Diagnostics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Customer Segment
|
Customer Segment
|
-
|
Customer Segment
|